Contineum Therapeutics (CTNM) Research & Development (2023 - 2026)
Contineum Therapeutics (CTNM) recorded Research & Development of $15.99 million in Q3 2026, up 45.4% from $10.99 million a year earlier and up 25.8% from the prior quarter.
Powered by 
Analysis
Contineum Therapeutics (CTNM) Research & Development (2023 - 2026) Analysis & Trends
On a TTM basis, Contineum Therapeutics' Research & Development came in at $53.09 million as of Sep 30, 2026, up 2.5% year-over-year; for FY2025, it came in at $51.52 million, up 34.1% from FY2024.
- Across earlier years, Research & Development came in at $38.42 million in FY2024 (+39.2%) and $27.6 million in FY2023.
- The Q3 2026 figure is the highest quarterly Research & Development in data going back to Q1 2023.
- On a year-over-year basis, Research & Development rose in five of the last eight quarters, with growth averaging 31.1%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 114.2% in Q1 2024, against a decline of 16.5% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $12.7 million (Q2 2026), $11.65 million (Q1 2026) and $12.76 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Contineum Therapeutics | 405.40 Mn | -584.86 Mn | - | 15.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 15.99 Mn |
| Jun 30, 2026 | 12.70 Mn |
| Mar 31, 2026 | 11.65 Mn |
| Dec 31, 2025 | 12.76 Mn |
| Sep 30, 2025 | 10.99 Mn |
| Jun 30, 2025 | 14.06 Mn |
| Mar 31, 2025 | 13.71 Mn |
| Dec 31, 2024 | 13.02 Mn |
| Sep 30, 2024 | 9.73 Mn |
| Jun 30, 2024 | 7.90 Mn |
| Mar 31, 2024 | 7.78 Mn |
| Dec 31, 2023 | 8.01 Mn |
| Sep 30, 2023 | 6.50 Mn |
| Jun 30, 2023 | 9.46 Mn |
| Mar 31, 2023 | 3.63 Mn |
API Access
Contineum Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CTNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CTNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CTNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();